FDA DEVICE FACTS
CASSATT™ SIJ Fixation System
Ctl Medical Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The CASSATT™ SIJ Fixation System is intended for fixation of sacroiliac joint disruptions and intended for sacroiliac joint fusion for conditions including:
• Sacroiliac joint disruptions,
• Degenerative sacroiliitis,
• To augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion and
• Acute, non-acute, and non-traumatic fractures involving the sacroiliac joint.
V. Comparison of Technological Characteristics with the Predicate Device: (Substantial Equivalence)
The subject device ‘CASSATT™ SIJ Fixation System’ and the primary predicate ‘Triton Sacroiliac Joint Fixation System’ (K211449) and additional predicates ‘Siconus SI Joint Fixation System (K162121), ‘Synthes Cannulated Screws’ (K021932) have the same intended use/indication for use, materials, technological characteristics, and principles of operation. Thus, the CASSATT™ SIJ Fixation System is substantially equivalent to the primary and additional predicates .
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。